McKesson buys Canadian drug store chain

Article Excerpt

MCKESSON CORP. $157 (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 229.0 million; Market cap: $36.0 billion; Price-to-sales ratio: 0.2; Dividend yield: 0.7%; TSINetwork Rating: Above Average; www.mckesson .com) is buying the Rexall chain of 470 drug stores in Canada for $2.2 billion. The company expects to complete the purchase by the end of 2016. McKesson already distributes prescription drugs and other products to Rexall, and this familiarity helps cut the risk of an unpleasant surprise. Excluding integration charges and currency exchange rates, the company expects the new operations will add to its earnings in the first year. McKesson is a hold. hold…